I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Natalizumab-immunogenicity evaluation in patients with infu..:
Nicolás Lundahl Ciano-Petersen
;
Pablo Aliaga-Gaspar
;
Isaac Hurtado-Guerrero
...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1242508/full. , 2023
Link:
https://doi.org/10.3389/fimmu.2023.1242508
RT Journal T1
Natalizumab-immunogenicity evaluation in patients with infusion related events or disease exacerbations
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:69a9e4df8ba44145a8f368bdc96332ab&Exemplar=1&LAN=DE A1 Nicolás Lundahl Ciano-Petersen A1 Pablo Aliaga-Gaspar A1 Isaac Hurtado-Guerrero A1 Virginia Reyes A1 José Luis Rodriguez-Bada A1 Eva Rodriguez-Traver A1 Isabel Brichette-Mieg A1 Laura Leyva Fernández A1 Pedro Serrano-Castro A1 Ana Alonso A1 Begoña Oliver-Martos PB Frontiers Media S.A. YR 2023 K1 multiple sclerosis K1 natalizumab K1 immunogenicity K1 anti-drug antibodies K1 adverse events K1 exacerbations K1 Immunologic diseases. Allergy K1 RC581-607 JF https://www.frontiersin.org/articles/10.3389/fimmu.2023.1242508/full LK http://dx.doi.org/https://doi.org/10.3389/fimmu.2023.1242508 DO https://doi.org/10.3389/fimmu.2023.1242508 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)